In news that is bound to excite breast cancer patients and investors, Genentech/Roche/Immunogen issued press releases on August 26, 2012, confirming that their drug-of-the-moment T-DM1 (trastuzumab emtansine) offers… read more.
In order to promote the ongoing education in cancer care which is one of the objectives of the association the Cork branch holds an annual education update. In… read more.
A key goal of MIRT is to train and mentor the clinician scientists of the future. An Interview with Dr. Peter O’Gorman, Consultant Haematologist, at the Mater University… read more.
A key goal of MIRT is to train and mentor the clinician scientists of the future. An Interview with Dr. Peter O’Gorman, Consultant Haematologist, at the Mater University… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
